Interní Med. 2008; 10(6): 298-304

ADVANCES IN PHARMACOTHERAPY OF PAIN

prof. MUDr. Miloslav Kršiak DrSc
Ústav farmakologie 3. LF UK, Praha

The paper draws attention to possibilities for improvements in pharmacotherapy of pain by making the best of guidelines and recommendations for treatment of pain elaborated in the Czech Republic and abroad in the last few years. There are given comments and links to several guidelines available in full length in the Internet: guidelines for pharmacotherapy of acute pain, chronic non-cancer pain, cancer pain, headache, post-operation pain, recommendations of EULAR for management of osteoarthritis and EFNS guidelines on pharmacological treatment of neuropathic pain. New analgesics introduced in the Czech Republic recently are briefly mentioned. The second part of the article deals with risks of pharmacotherapy of pain with respect to resent findings on risks in the treatment with nonsteroid antiinflammatory drugs, opioids, paracetamol and dipyrone. There are given links to the statement of American Heart Association on use of nonsteroid antiinflammatory drugs and to some documents of IASP on efects and use of opioid analgesics.

Keywords: Key words: pharmacotherapy of pain, guidelines, recommendations, analgesics, adverse reactions.

Published: July 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kršiak M. ADVANCES IN PHARMACOTHERAPY OF PAIN. Interní Med. 2008;10(6):298-304.
Download citation

References

  1. Oxford league table of analgesics in acute pain. [on line] 2008. Dostupná z WWW: http://www.jr2.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/Leagtab.html.
  2. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. Journal of Clinical Epidemiology 1998; 51: 1357-1365. Go to original source... Go to PubMed...
  3. Angst MS, Clark JD. Opioid-induced hyperalgesia - A qualitative systematic review. Anesthesiology 2006; 104: 570-587. Go to original source... Go to PubMed...
  4. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association. Circulation 2007; 115: 1634-1642 Dostupný také na WWW: http://circ.ahajournals.org/cgi/content/full/115/12/1634. Go to original source... Go to PubMed...
  5. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology 2006; 13: 1153-1169. Dostupný také na WWW: http://www.guideline.gov/summary/summary.aspx?doc_id=10472&nbr=5495&ss=6&xl=999. Go to original source... Go to PubMed...
  6. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain 2006; 10: 287-333. Go to original source... Go to PubMed...
  7. Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, Rimm EB, Willett WC, Fuchs CS. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006; 113: 1578-1587. Go to original source... Go to PubMed...
  8. Dart RC, Bailey E. Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy 2007; 27: 1219-1230. Go to original source... Go to PubMed...
  9. Eisenberg E, Marinangeli F, Birkhahn J, Paladini A, Varrassi G. Time to modify the WHO analgesic ladder? Pain Clinical Updates 2005; 13: 1-4 Dostupný také na WWW: http://www.iasp-pain.org/AM/AMTemplate.cfm?Section=Home&CONTENTID=2266&TEMPLATE=/CM/ContentDisplay.cfm.
  10. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults - Results of a US consensus panel of experts. Archives of Internal Medicine 2003; 163: 2716-2724. Go to original source... Go to PubMed...
  11. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. British Medical Journal 2006; 332: 1302-1305. Go to original source... Go to PubMed...
  12. Kozák J, Lejčko J, Kršiak M. Farmakoterapie chronické nenádorové bolesti. Doporučený postup. 2004. Dostupný také z WWW: http://www.svl.cz/Files/public/svl/Dp_2004/Farmakoterapie_Bolesti.pdf.
  13. Kršiak M, Kozák J, Lejčko J, Skála B. Farmakoterapie akutní bolesti. Doporučený postup. 2004. Dostupný také z WWW: http://www.svl.cz/Files/public/svl/Dp_2004/Farmakoterapie_Bolesti.pdf.
  14. Málek J, Príkazský V, Dáňová J, Kurzová A, Kozák J, Lengálová E. Výskyt bolesti v populaci České republiky - pilotní studie. Bolest 2003; 6: 113-122.
  15. Marková J, Skála B, Keller O, Mastík J, Konštacký S, Waberžinek G. Bolesti hlavy. Doporučený postup 2007. Dostupný také z WWW: http://www.svl.cz/Files/nastenka/page_4766/Version1/Bolesti-hlavy.pdf.
  16. McNicol E. Opioid side effects. Pain Clinical Updates 2007; 15: 1-6 Dostupný také na WWW: http://www.iasp-pain.org/AM/AMTemplate.cfm?Section=Home&TEMPLATE=/CM/ContentDisplay.cfm&CONTENTID=3852.
  17. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. New England Journal of Medicine 2005; 352: 1081-1091. Go to original source... Go to PubMed...
  18. Pavelka K. Léčba bolesti u osteoartrózy. Bolest 2006; 9: 20. EULAR doporučený postup je dostupný na WWW: http://ard.bmj.com/cgi/content/full/64/5/669.
  19. Prescott LF. Paracetamol, alcohol and the liver. Br. J. Clin. Pharmacol. 2000; 49: 291-301. Go to original source... Go to PubMed...
  20. Rokyta R. Bolest zad. Plzeň: Adéla - grafické studio 2008. v tisku.
  21. Seager JM, Hawkey CJ. ABC of the upper gastrointestinal tract - Indigestion and non-steroidal antiinflammatory drugs. British Medical Journal 2001; 323: 1236-1239. Go to original source... Go to PubMed...
  22. Seifert B, Dítě P, Bureš J, Pavelka K, Forejtová Š, Hep A, Jirásek V, Koudelka T, Lukáš K, Štolfa J, Vencovský J, Vojtíšková J. Rizika a prevence nežádoucích účinků nesteroidních antiflogistik a kyseliny acetylsalicylové. Mezioborové konsenzuální doporučení pro praktické lékaře. Prakt. Lék. 2006; 86: 38-42.
  23. Ševčík P, Málek J, Bejšovec D, Gabrhelík T, Křikava I, Lejčko J, Mach D, Mixa V, Vojtíšková M. Léčba akutní pooperační bolesti. Doporučený postup. 2008 Dostupný z WWW: http://www.pain.cz/file-content/Bolest_CSARIM_130308_1_.pdf.
  24. Sláma O. Mírnění bolestí u umírajících nemocných. Klin Farmakol Farm 2007; 21: 59-61.
  25. Sláma O, Vorlíček J, Ševčík P, Hakl M, Doležal T. Farmakoterapie chronické nádorové bolesti. Doporučený postup 2004. Dostupný z WWW: http://www.svl.cz/Files/nastenka/page_4766/Version1/Farmakoterapie-bolesti.pdf.
  26. Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily - A randomized controlled trial. Jama-Journal of the American Medical Association 2006; 296: 87-93. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.